A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/66 (2006.01) A61K 31/06 (2006.01) A61K 31/44 (2006.01) A61K 31/663 (2006.01) A61P 19/10 (2006.01)
Patent
CA 2213076
Alendronate, a bisphosphonate, when administered daily over a substantial period of time, can reduce the rate of vertebral fractures in post-menopausal women. Further it can reduce the number and severity of fractures. Also, administration of alendronate can prevent spinal deformity, and loss in height.
Cette invention concerne un biphosphonate, plus précisément un alendronate, qui, lorsqu'il est administré quotidiennement pendant une période suffisamment longue, permet de diminuer le taux de fractures vertébrales chez les femmes en situation postménopausique. Cet alendronate peut également diminuer le nombre et la gravité des fractures. L'administration d'alendronate peut enfin prévenir les déformations spinales ainsi que l'amenuisement de la taille.
Capizzi Thomas P.
Karpf David B.
Quan Hui
Santora Arthur C. II
Yates Ashley J.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Method of lessening the risk of vertebral fractures does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of lessening the risk of vertebral fractures, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of lessening the risk of vertebral fractures will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1912987